Maheshwari Anurag, Yoo Hwan Y, Thuluvath Paul J
Department of Medicine, The Johns Hopkins University School of Medicine Baltimore, Maryland 21205, USA.
Am J Gastroenterol. 2004 Mar;99(3):538-42. doi: 10.1111/j.1572-0241.2004.04050.x.
Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are reported to have the best outcomes after liver transplantation. Based on excellent 5-yr survival results after transplantation, it has been suggested that PSC patients may benefit from "preemptive" transplantation to reduce the risk of cholangiocarcinoma. In this study, we compared 10-yr survival of patients with PSC and PBC using a large database after adjusting for other confounding risk factors.
The United Network for Organ Sharing (UNOS) database of all patients who had liver transplantation from 1987 to 2001 was used for analysis after excluding patients with multiple organ transplantation, children, and incomplete data.
Patients with PSC (n = 3,309) were younger than those with PBC (n = 3,254). Retransplantation rate was high in PSC (12.4%vs 8.5%; p< 0.01), and PSC was an independent predictor for retransplantation on multivariate analysis. Cox regression analysis showed that PSC patients had significantly lower graft and patient survival compared to PBC patients after adjusting for other risk factors. Lower survival in PSC became apparent 7 yr after transplantation.
Patients with PSC had a higher retransplantation rate and lower survival when compared to PBC. Based on this analysis, we do not recommend preemptive liver transplantation for patients with PSC.
据报道,原发性胆汁性肝硬化(PBC)和原发性硬化性胆管炎(PSC)患者在肝移植后预后最佳。基于移植后出色的5年生存率结果,有人提出PSC患者可能从“抢先”移植中获益,以降低胆管癌风险。在本研究中,我们在调整其他混杂风险因素后,使用一个大型数据库比较了PSC和PBC患者的10年生存率。
使用器官共享联合网络(UNOS)数据库中1987年至2001年接受肝移植的所有患者的数据进行分析,排除多器官移植患者、儿童和数据不完整的患者。
PSC患者(n = 3309)比PBC患者(n = 3254)年轻。PSC患者的再次移植率较高(分别为12.4%和8.5%;p < 0.01),多因素分析显示PSC是再次移植的独立预测因素。Cox回归分析表明,在调整其他风险因素后,PSC患者的移植物和患者生存率显著低于PBC患者。PSC患者较低的生存率在移植后7年变得明显。
与PBC患者相比,PSC患者的再次移植率更高,生存率更低。基于该分析,我们不建议对PSC患者进行抢先肝移植。